|
|
|
Having trouble viewing this email? View it as a Web page.
You are subscribed to one of CDC’s email subscription services: In the CVX Mapped To VIS Table the new CVX code for “Yellow fever vaccine – alt”, 183, has been mapped to the Yellow Fever Vaccine VIS.
|
Having trouble viewing this email? View it as a Web page.
You are subscribed to CDC News: Immunization-related MMWRs email subscription service. This message serves to inform you that one or more MMWRs have recently been added to the MMWR page and are now available. end of message |
Having trouble viewing this email? View it as a Web page.
You are subscribed to one or more CDC code sets email subscription services. This message serves to inform you that information has recently been updated and is now available. Links to all of the code sets can be found on the Code Sets web page. UPDATES: There is a correction to the NDC tables for Flublok. The vaccine trihibit has been set to inactive in the trade name table and the CVX table.
|
Having trouble viewing this email? View it as a Web page.
www.cdc.gov/vaccines/ed/ciinc/index.html You are subscribed to CDC’s Immunization-related Netconferences email subscription service. Get up-to-date information on Adult Immunization. A collaborative effort between the Centers for Disease Control and Prevention (CDC) and Maryland’s adult immunization coalition and state immunization program, the Vaccinating Adults series will feature six presentations by experts in promoting, administering, and securing reimbursement for adult immunizations. Registration information for the noon ET webinar can be found at http://www.cdc.gov/vaccines/ed/ciinc/index.html
|
Having trouble viewing this email? View it as a Web page.
You are subscribed to CDC’s Immunization-related Netconferences email subscription service. Get up-to-date information on the 2017 Immunization Schedules. The March 29 Current Issues in Immunization NetConference (CIINC) will provide health care professionals an update on the Advisory Committee on Immunization Practices (ACIP) recommendations for the 2017 Immunization Schedules. Registration information for the noon ET webinar can be found at www.cdc.gov/vaccines/ed/ciinc/index.html.
|
Having trouble viewing this email? View it as a Web page.
You are subscribed to CDC News: Immunization-related MMWRs email subscription service. This message serves to inform you that one or more MMWRs have recently been added to the MMWR page and are now available.
|
Having trouble viewing this email? View it as a Web page.
You are subscribed to one or more CDC code sets email subscription services. This message serves to inform you that information has recently been updated and is now available. Links to all of the code sets can be found on the Code Sets web page. UPDATES: The following tables have been updated to accommodate changes in availability of Yellow fever vaccine: The existing CVX for yellow fever vaccine has a new comment that identifies it as the one that has been in use for some years. A new CVX was created for the vaccine that will soon be used in the US. It has a note indicating the differences in the vaccine contents. A new CVX was created for yellow fever vaccine, unspecified formulation. The YellowFever vaccine group has been associated with the unspecified formulation CVX. The new CVX codes have been associated with the YellowFever vaccine group.
|
Having trouble viewing this email? View it as a Web page.
You are subscribed to one or more CDC code sets email subscription services. This message serves to inform you that information has recently been updated and is now available. Links to all of the code sets can be found on the Code Sets web page. UPDATES: The following tables have been updated to accommodate changes in availability of Yellow fever vaccine: The existing CVX for yellow fever vaccine has a new comment that identifies it as the one that has been in use for some years. A new CVX was created for the vaccine that will soon be used in the US. It has a note indicating the differences in the vaccine contents. A new CVX was created for yellow fever vaccine, unspecified formulation. The YellowFever vaccine group has been associated with the unspecified formulation CVX. The new CVX codes have been associated with the YellowFever vaccine group.
|
Having trouble viewing this email? View it as a Web page.
You are subscribed to CDC’s Pink Book email subscription service. The following information has recently been updated and is now available. Three items in the Pink Book’s appendices have been updated in the online edition: “Vaccine Excipient and Media Summary” in Appendix B, and “CDC Contact Information and Resources” and “Immunization Grantee List” in Appendix F. end of message |